Finding 969094 (2020-107)

Material Weakness
Requirement
ABH
Questioned Costs
-
Year
2020
Accepted
2024-04-09
Audit: 302957
Organization: Pancare of Florida, INC (FL)

AI Summary

  • Core Issue: ACH payments lack proper review and approval, risking non-compliance with federal requirements.
  • Impacted Requirements: Internal controls under 2 CFR section 200.303 and cost principles at 45 CFR part 75, affecting allowable costs and period of performance.
  • Recommended Follow-Up: Develop and implement documented policies for ACH payment processing and review to ensure compliance and prevent funding loss.

Finding Text

2020-107 Lack of ACH Payment Review and Approval (initially reported 2020) Assistance Listing Number: 93.224 Name of Federal Agency: Department of Health and Human Services, HRSA Program Title: Health Center Program (Community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) Compliance Requirement: Activities Allowed, Allowable Costs and Period of Performance Pass-through Entity: N/A Federal Grant/Contract Number and Grant Year: 6H80CS06452-15 (2020), COVID-19 1H8CCS35035-01 (2020), COVID-19 1H8DCS36007-01 (2020) and COVID-19 1H8ECS39010-01 (2020) Finding Type: Material Weakness in Internal Control Known Questioned Costs: $0 Condition: Payments are not reviewed prior to ACH payments. The Organization has no documented policies and procedures for handling the processing and review of ACH payments. Criteria: 2 CFR section 200.303 requires that nonfederal entities receiving federal awards establish and maintain internal control over the federal awards that provides reasonable assurance that the nonfederal entity is managing the federal awards in compliance with federal statutes, regulations, and the terms and conditions of the federal awards. Based on grant compliance requirements related to activities allowed and allowable costs, costs charged to federal programs under the HCP award must comply with the cost principles at 45 CRF part 75, subpart E, and any other requirements or restrictions on the use of federal funds. Based on compliance requirements related to period of performance, federal awards are charged for (a) allowable costs incurred during the period of performance: or (b) costs incurred prior to the date the federal award was made that were authorized by the federal awarding agency or pass-through entity. Cause: The payment for expenses under the program were not reviewed prior to payment for allowability of costs and whether the costs were incurred during the period of performance. Effect: The Organization could report costs that were not allowable or not incurred during the period of performance which could result in losing funding. Recommendation: We recommend the Organization develop policies and procedures related to processing and reviewing ACH payments under federal award programs for allowability of costs and determination of whether the costs were incurred during the period of performance.  Views of Responsible Officials and Planned Corrective Action: The Organization has hired a new Chief Financial Officer as well as additional supporting staff within the finance department. Management understands the importance of reviewing ACH payments prior to payment. We will update our policy to include a process for ACH reviews prior to payment. The planned corrective action for this finding is currently in the process of development, approval, and implementation.

Categories

Allowable Costs / Cost Principles Subrecipient Monitoring HUD Housing Programs Material Weakness Period of Performance Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 392647 2020-101
    Material Weakness Repeat
  • 392648 2020-102
    Significant Deficiency Repeat
  • 392649 2020-104
    Significant Deficiency Repeat
  • 392650 2020-105
    Significant Deficiency
  • 392651 2020-106
    Material Weakness
  • 392652 2020-107
    Material Weakness
  • 392653 2020-108
    Significant Deficiency
  • 392654 2020-101
    Material Weakness Repeat
  • 392655 2020-102
    Significant Deficiency Repeat
  • 392656 2020-104
    Significant Deficiency Repeat
  • 392657 2020-105
    Significant Deficiency
  • 392658 2020-106
    Material Weakness
  • 392659 2020-107
    Material Weakness
  • 392660 2020-108
    Significant Deficiency
  • 392661 2020-101
    Material Weakness Repeat
  • 392662 2020-102
    Significant Deficiency Repeat
  • 392663 2020-104
    Significant Deficiency Repeat
  • 392664 2020-105
    Significant Deficiency
  • 392665 2020-106
    Material Weakness
  • 392666 2020-107
    Material Weakness
  • 392667 2020-108
    Significant Deficiency
  • 392668 2020-101
    Material Weakness Repeat
  • 392669 2020-102
    Significant Deficiency Repeat
  • 392670 2020-104
    Significant Deficiency Repeat
  • 392671 2020-105
    Significant Deficiency
  • 392672 2020-106
    Material Weakness
  • 392673 2020-107
    Material Weakness
  • 392674 2020-108
    Significant Deficiency
  • 969089 2020-101
    Material Weakness Repeat
  • 969090 2020-102
    Significant Deficiency Repeat
  • 969091 2020-104
    Significant Deficiency Repeat
  • 969092 2020-105
    Significant Deficiency
  • 969093 2020-106
    Material Weakness
  • 969095 2020-108
    Significant Deficiency
  • 969096 2020-101
    Material Weakness Repeat
  • 969097 2020-102
    Significant Deficiency Repeat
  • 969098 2020-104
    Significant Deficiency Repeat
  • 969099 2020-105
    Significant Deficiency
  • 969100 2020-106
    Material Weakness
  • 969101 2020-107
    Material Weakness
  • 969102 2020-108
    Significant Deficiency
  • 969103 2020-101
    Material Weakness Repeat
  • 969104 2020-102
    Significant Deficiency Repeat
  • 969105 2020-104
    Significant Deficiency Repeat
  • 969106 2020-105
    Significant Deficiency
  • 969107 2020-106
    Material Weakness
  • 969108 2020-107
    Material Weakness
  • 969109 2020-108
    Significant Deficiency
  • 969110 2020-101
    Material Weakness Repeat
  • 969111 2020-102
    Significant Deficiency Repeat
  • 969112 2020-104
    Significant Deficiency Repeat
  • 969113 2020-105
    Significant Deficiency
  • 969114 2020-106
    Material Weakness
  • 969115 2020-107
    Material Weakness
  • 969116 2020-108
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.224 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $6.42M
93.461 Covid-19 Testing for the Uninsured $498,180
93.224 Covid-19 Consolidated Health Centers (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $97,607
93.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $78,345
93.982 Mental Health Disaster Assistance and Emergency Mental Health $49,401
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $9,319